By Nerac IP Analysts
The major idea behind the Bayh-Dole act passed in 1980 was to move control of technology discovered under federal grant funding from the federal government itself to universities. The goal was to speed development of new technology from university labs to the marketplace. How that was to be done was not specified in the legislation nor was any new enabling funding provided. The initial idea seems straight-forward enough, but of course, implementation has been sporadic and variably effective. By some estimates, the value of developed technology has been equivalent to approximately one or two percent of the initial research expense. This, of course, raises questions about how effective technology transfer has been and how effective we should expect it to be. This report is motivated by the desire to understand what is happening in technology transfer (TT) especially in the US. What are the limitations and challenges in TT? Have they changed in recent years, especially after the shock in economic conditions beginning in 2007-2008?
Download the complete article here.
The article is free!
Simply fill in the form below, verify your email address
and you’ll be sent a link to download the article.
Related Posts
- 80By John Leavitt, Ph.D. Nerac Analyst, Originally Published: July 23, 2014 Universities are hotbeds for innovation and entrepreneurship – take, for example, Stanford University, MIT, and Harvard. In the case of Stanford all you have to do is to look up Page Mill Road in Palo Alto, California, and the surrounding Silicone Valley to see the…
- 43By Kevin Closson, Nerac Analyst, Originally published June, 2013 One of the most pressing issues for companies big and small, in every industry, is the need to stay relevant in their markets. Innovation is rightly seen as the chief way to achieve this goal. It is also widely acknowledged that innovation cannot be the only province…
- 41Originally published September, 2008 Food makers increasingly rely on patented technologies to improve functionality, but strict regulations hamper marketing benefits. The United States functional foods market is relatively immature compared to that of nutraceuticals. From an intellectual property standpoint, this may be because functional food technology develops from within the food industry, while nutraceuticals may…